Alpha Healthcare Acquisition Corp. III (ALPA) Closes Carmell Deal
by Nicholas Alan Clayton on 2023-07-14 at 3:43pm

Alpha Healthcare Acquisition Corp. III (NASDAQ:ALPA) announced this afternoon that it has closed its combination with drug developer Carmell having secured shareholder approval at a special meeting on July 11.

The combined company’s shares and warrants are expected to begin trading on the Nasdaq under the symbols “CTCX” and “CTCXW” on July 17.

The SPAC also divulged in an 8-K that it had better-than-average redemptions in the end with 81.5% of shares redeemed, leaving it with $29.5 million in trust.

It achieved this result thanks in part to a non-redemption agreement and forward purchase agreement it signed earlier this week through which Meteora Capital Partners agreed to hold onto 9.5% of its equity through close. After expenses, Alpha Healthcare III expects Carmell to add $16.1 million to its balance sheet.

Some of that capital may be immediately put to work as the parties announced they had signed an LOI to acquire a commercial-stage biotech firm following close for $8 million in cash and $57 million in Carmell stock.

Alpha Healthcare III initially inked the $188 million merger with Carmell in January. Pittsburgh-based Carmell is developing a treatment platform to accelerate healing in bone fractures and soft tissue wounds.


ADVISORS

  • Goodwin Procter LLP acted as legal counsel to Alpha Healthcare III.
  • Troutman Pepper Hamilton Sanders LLP acted as legal counsel to Carmell.
Recent Posts
by Nicholas Alan Clayton on 2025-05-05 at 8:10am

At the SPAC of Dawn Last week’s hot streak continues this week in the form of a high volume of votes for SPACs. Two are seeking approvals for their business combinations while six more aim to get the stamp on their extension votes. Investors will also have an eye on upcoming Fed comments on Wednesday...

by Kristi Marvin on 2025-05-03 at 10:02am

Terms Tracker for the Week Ending May 2, 2025 Welcome to our weekly column where we discuss the findings from our IPO terms tracker based on the previous week’s pricings. April wrapped with some real momentum. Over the course of the month, 19 SPACs filed new S-1s, while 12 IPOs priced. Furthermore, nine deal announcements...

by Nicholas Alan Clayton on 2025-05-02 at 3:21pm

ProCap Acquisition Corp. (NASDAQ:PCAPU) has filed for a $200 million SPAC to hunt for a fintech or financial services target. The new S-1 filing was BTIG’s second of the week after a two-month break, bringing its 2025 new SPAC filings to five and the bank has so far managed to IPO five SPACs as well....

by Nicholas Alan Clayton on 2025-05-02 at 12:09pm

MSM Frontier Capital Acquisition Corp. (NASDAQ:MSMUU) has filed for a $225 million SPAC to search for a infrastructure target in Africa. The new SPAC will head out on this expedition with a trust that is not overfunded and units that each contain one right to a 1/8 share. It will also have 24 months to...

by Nicholas Alan Clayton on 2025-05-02 at 8:25am

At the SPAC of Dawn This action-packed week in SPACs comes to an end with three more SPACs launching their IPOs, bringing it to nine on the week. And, the crypto strategy that SPACInsider noticed becoming increasingly popular among de-SPACs earlier this year has continued to gain steam. This week, edtech firm Classover (NASDAQ:KIDZ), fresh...

logo

Copyright © 2025 SPACInsider, Inc. All Rights Reserved